Malawi

You are here:-Malawi
Malawi2018-11-11T12:01:45+00:00

Malawi is a land-locked country located in Southern-Central Africa, sharing borders with Tanzania, Zambia, and Mozambique. It has a land area of about 118,484 km2, with a projected population of about 16.4 million. The country is divided into three geographical regions (north, central, and south). There are 28 districts organized into five health zones (Northern Zone, Central-Eastern Zone, Central Western Zone, South Eastern Zone, and South Western Zone).

TB remains a major public health problem in Malawi. According to 2014 WHO report, there were an estimated 16,267 new cases of TB (all forms) in the year 2014, and approximately 54% of these were HIV positive. The prevalence of TB (all forms) in the country was estimated at 334 per 100,000.

The TB CARE II Malawi Project is a coordinated effort led by URC in collaboration with Project HOPE and Partners in Health. The project aims to:

  1. work with the government of Malawi to reach and sustain global and national targets for case detection and treatment success through DOTS expansion and strengthening;
  2. scale up universal access to TB diagnosis and treatment, especially in women and vulnerable populations, utilizing community-based approaches;
  3. improve TB/HIV integration at all levels, particularly at the health facility level, and offer high-quality DOTS through a wider range of service delivery outlets, especially for PLHIV;
  4. increase access to drug-resistant TB prevention and treatment through community-based approaches and improved diagnostic capacity for drug-susceptible and drug-resistant TB.

The major project interventions are focused on both the national and district levels, in close collaboration with the National Tuberculosis Program (NTP) and the Ministry of Health. At the national level, this includes strengthening the laboratory network and improving the Central Reference Laboratory (CRL) capacity, supporting the nascent drug-resistant TB (DRTB) treatment program, piloting novel diagnostics, and strengthening the NTP centrally. Activities in target districts are focused on implementing a comprehensive package that includes: emphasis on DOTS expansion and enhancement, integration of TB/HIV services, improved services for DRTB and health system strengthening through the decentralization of services, improvement of the laboratory network, and involvement of community structures in the diagnosis and patient follow-up. TB CARE II works in Machinga, Mangochi, Mulanje, Neno, Ntcheu, Phlalombe, Nsanje, Nkhotakota, Mzimba, Balaka, Zomba, Lilongwe, and Chikwawa.

              

News Related to TB and Malawi

USAID TB CARE II PROJECT SAVES LIVES OF COMMUNITIES IN MANGOCHI

THE EXPERIENCE OF CATHERINE PELANI Access to health care services among rural, resource-poor people in low-income countries remains a major obstacle to TB control efforts. A critical factor is the need to improve access to diagnostic facilities, which in many rural areas double as TB treatment initiation and registration centers for TB patients. It is common for patients to travel over 50 kilometers to access TB treatment initiation services.

TB/HIV IMPLEMENTATION AND INTEGRATION – FORMATION OF TB/HIV STRUCTURES AT DISTRICT LEVEL

Following successful formation of three District TB/HIV committees in Nsanje, Phalombe and Machinga in November, TB CARE II facilitated the establishment of four more committees in Mzimba, Mangochi, Neno and Zomba districts. A total of 61 Health Care Workers (45 males, 16 females) participated in the orientation and formation of these committees in the four districts. In Machinga and Balaka the TB/HIV committees conducted their first meetings where they

PROMOTING INTEGRATED TB/HIV SERVICES THROUGH ONE-STOP-SHOP MODEL IN MALAWI

Malawi has an HIV prevalence rate of 10.3% and a TB incidence rate of 163 per 100,000. Nearly 60% of TB patients are co-infected with HIV. TB is the leading cause of death among people living with HIV/AIDS. HIV-positive TB patients have worse treatment outcomes than HIV-negative TB patients, and TB-related mortality among TB/HIV co-infected patients is particularly high during the first two to three months of TB treatment.

“BETTER SAFE THAN SORRY”: TB CARE II MALAWI PROMOTES ACTIVE TB SCREENING AMONG HIV-POSITIVE TEACHERS AND LEARNERS

In an effort to improve TB/HIV integration in the country, TB CARE II Malawi is collaborating with the Ministries of Health and Education to increase TB screening among HIV-positive school teachers and learners. Working under the motto, “Better Safe than Sorry”, the campaign is encouraging HIV positive individuals to be screened routinely for TB – in order to identify and treat the disease early, rather than risk waiting to develop

TB CARE II PROJECT OVERVIEW

The USAID TB CARE II Project, a five-year project implemented by a wide consortium of health and development organizations including and led by University Research Co., LLC (URC), began in 2010 with the aim of complementing and building upon existing and planned projects in the Bureau for Global Health to provide global leadership and support to National TB Programs and other in-country partners. Since then, the project team has

URC Participation at the 48th Annual Union World Conference on Lung Health

The Union World Conference on Lung Health continues to be the largest gathering of clinicians and public health professionals, program managers, policymakers, researchers, and advocates working to end the suffering caused by TB and other lung diseases. The 48th annual conference, held in Guadalajara, Mexico on October 11-14, 2017, continued this tradition with fruitful discussions, research presentations, and other cutting-edge developments. This year’s theme – Accelerating Toward Elimination –